                               SEQUENCE LISTING

<110> THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
 
<120> MONOVALENT AND MULTIVALENT VACCINES FOR PREVENTION AND TREATMENT 
      OF DISEASE

<130> 114198-9992

<140> PCT/US2022/011722
<141> 2022-01-07

<150> 63/237,378
<151> 2021-08-26

<150> 63/135,492
<151> 2021-01-08

<160> 53    

<170> PatentIn version 3.5

<210> 1
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Lys Thr Thr Lys Gln Ser Phe Asp Leu Ser Val Lys Ala Gln Tyr Lys 
1               5                   10                  15      


Lys Asn Lys His 
            20  


<210> 2
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Phe Gly Phe Pro Glu His Leu Leu Val Asp Phe Leu Gln Ser Leu Ser 
1               5                   10                  15      


<210> 3
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<400> 3
Asn Val Pro Glu Glu Asp Gly Thr Arg Phe His Arg Gln Ala Ser Lys 
1               5                   10                  15      


Cys 
    


<210> 4
<211> 15
<212> PRT
<213> Alphapapillomavirus 9

<400> 4
Gln Leu Tyr Lys Thr Cys Lys Gln Ala Gly Thr Cys Pro Pro Asp 
1               5                   10                  15  


<210> 5
<211> 8
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 5
Lys Gly Ile Tyr Gln Thr Ser Asn 
1               5               


<210> 6
<211> 17
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 6
Ala Ile Ser Ser Val Leu Asn Asp Ile Leu Ser Arg Leu Asp Lys Val 
1               5                   10                  15      


Glu 
    


<210> 7
<211> 17
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 7
Lys Asn His Thr Ser Pro Asp Val Asp Leu Gly Asp Ile Ser Gly Ile 
1               5                   10                  15      


Asn 
    


<210> 8
<211> 22
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 8
Glu Ile Asp Arg Leu Asn Glu Val Ala Lys Asn Leu Asn Glu Ser Leu 
1               5                   10                  15      


Ile Asp Leu Gln Glu Leu 
            20          


<210> 9
<211> 17
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 9
Ala Thr Arg Phe Ala Ser Val Tyr Ala Trp Asn Arg Lys Arg Ile Ser 
1               5                   10                  15      


Asn 
    


<210> 10
<211> 18
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 10
Tyr Asn Ser Ala Ser Phe Ser Thr Phe Lys Cys Tyr Gly Val Ser Pro 
1               5                   10                  15      


Thr Lys 
        


<210> 11
<211> 15
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 11
Leu Pro Asp Pro Ser Lys Pro Ser Lys Arg Ser Phe Ile Glu Asp 
1               5                   10                  15  


<210> 12
<211> 5
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 12
Phe Arg Lys Ser Asn 
1               5   


<210> 13
<211> 18
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 13
Pro Ser Lys Pro Ser Lys Arg Ser Phe Ile Glu Asp Leu Leu Phe Asn 
1               5                   10                  15      


Lys Val 
        


<210> 14
<211> 18
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 14
Thr Glu Ser Asn Lys Lys Phe Leu Pro Phe Gln Gln Phe Gly Arg Asp 
1               5                   10                  15      


Ile Ala 
        


<210> 15
<211> 12
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 15
Thr Glu Ser Asn Lys Lys Phe Leu Pro Phe Gln Gln 
1               5                   10          


<210> 16
<211> 12
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 16
His Ala Asp Gln Leu Thr Pro Thr Trp Arg Val Tyr 
1               5                   10          


<210> 17
<211> 12
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 17
Phe Lys Glu Glu Leu Asp Lys Tyr Phe Lys Asn His 
1               5                   10          


<210> 18
<211> 15
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 18
Phe Ala Ser Thr Glu Lys Ser Asn Ile Ile Arg Gly Trp Ile Phe 
1               5                   10                  15  


<210> 19
<211> 15
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 19
Pro Phe Leu Gly Val Tyr Tyr His Lys Asn Asn Lys Ser Trp Met 
1               5                   10                  15  


<210> 20
<211> 15
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 20
Glu Val Arg Gln Ile Ala Pro Gly Gln Thr Gly Lys Ile Ala Asp 
1               5                   10                  15  


<210> 21
<211> 16
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 21
Asn Asn Leu Asp Ser Lys Val Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg 
1               5                   10                  15      


<210> 22
<211> 16
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 22
Asn Asn Leu Asp Ser Lys Val Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg 
1               5                   10                  15      


<210> 23
<211> 15
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 23
Leu Phe Arg Lys Ser Asn Leu Lys Pro Phe Glu Arg Asp Ile Ser 
1               5                   10                  15  


<210> 24
<211> 133
<212> PRT
<213> Escherichia virus Qbeta

<400> 24
Met Ala Lys Leu Glu Thr Val Thr Leu Gly Asn Ile Gly Lys Asp Gly 
1               5                   10                  15      


Lys Gln Thr Leu Val Leu Asn Pro Arg Gly Val Asn Pro Thr Asn Gly 
            20                  25                  30          


Val Ala Ser Leu Ser Gln Ala Gly Ala Val Pro Ala Leu Glu Lys Arg 
        35                  40                  45              


Val Thr Val Ser Val Ser Gln Pro Ser Arg Asn Arg Lys Asn Tyr Lys 
    50                  55                  60                  


Val Gln Val Lys Ile Gln Asn Pro Thr Ala Cys Thr Ala Asn Gly Ser 
65                  70                  75                  80  


Cys Asp Pro Ser Val Thr Arg Gln Ala Tyr Ala Asp Val Thr Phe Ser 
                85                  90                  95      


Phe Thr Gln Tyr Ser Thr Asp Glu Glu Arg Ala Phe Val Arg Thr Glu 
            100                 105                 110         


Leu Ala Ala Leu Leu Ala Ser Pro Leu Leu Ile Asp Ala Ile Asp Gln 
        115                 120                 125             


Leu Asn Pro Ala Tyr 
    130             


<210> 25
<211> 190
<212> PRT
<213> Cowpea chlorotic mottle virus

<400> 25
Met Ser Thr Val Gly Thr Gly Lys Leu Thr Arg Ala Gln Arg Arg Ala 
1               5                   10                  15      


Ala Ala Arg Lys Asn Lys Arg Asn Thr Arg Val Val Gln Pro Val Ile 
            20                  25                  30          


Val Glu Pro Ile Ala Ser Gly Gln Gly Lys Ala Ile Lys Ala Trp Thr 
        35                  40                  45              


Gly Tyr Ser Val Ser Lys Trp Thr Ala Ser Cys Ala Ala Ala Glu Ala 
    50                  55                  60                  


Lys Val Thr Ser Ala Ile Thr Ile Ser Leu Pro Asn Glu Leu Ser Ser 
65                  70                  75                  80  


Glu Arg Asn Lys Gln Leu Lys Val Gly Arg Val Leu Leu Trp Leu Gly 
                85                  90                  95      


Leu Leu Pro Ser Val Ser Gly Thr Val Lys Ser Cys Val Thr Glu Thr 
            100                 105                 110         


Gln Thr Thr Ala Ala Ala Ser Phe Gln Val Ala Leu Ala Val Ala Asp 
        115                 120                 125             


Asn Ser Lys Asp Val Val Ala Ala Met Tyr Pro Glu Ala Phe Lys Gly 
    130                 135                 140                 


Ile Thr Leu Glu Gln Leu Thr Ala Asp Leu Thr Ile Tyr Leu Tyr Ser 
145                 150                 155                 160 


Ser Ala Ala Leu Thr Glu Gly Asp Val Ile Val His Leu Glu Val Glu 
                165                 170                 175     


His Val Arg Pro Thr Phe Asp Asp Ser Phe Thr Pro Val Tyr 
            180                 185                 190 


<210> 26
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> SITE
<222> (1)..(15)
<223> This sequence may encompass 1-5 "Gly Ser Gly"
      repeating units

<400> 26
Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly 
1               5                   10                  15  


<210> 27
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> SITE
<222> (1)..(20)
<223> This sequence may encompass 1-5 "Gly Gly Ser Gly"
      repeating units

<400> 27
Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly 
1               5                   10                  15      


Gly Gly Ser Gly 
            20  


<210> 28
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> SITE
<222> (1)..(20)
<223> This sequence may encompass 1-5 "Gly Pro Ser Leu"
      repeating units

<400> 28
Gly Pro Ser Leu Gly Pro Ser Leu Gly Pro Ser Leu Gly Pro Ser Leu 
1               5                   10                  15      


Gly Pro Ser Leu 
            20  


<210> 29
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> SITE
<222> (1)..(40)
<223> This sequence may encompass 1-5 
      "Gly Gly Ser Gly Gly Gly Ser Gly" repeating units

<400> 29
Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly 
1               5                   10                  15      


Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly 
            20                  25                  30          


Gly Gly Ser Gly Gly Gly Ser Gly 
        35                  40  


<210> 30
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 30
Gly Pro Ser Leu 
1               


<210> 31
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 31
Gly Gly Ser Gly Gly Gly Ser Gly 
1               5               


<210> 32
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 32
Cys Gly Gly Gly Phe Lys Gly Ile Tyr Gln Thr Ser Asn 
1               5                   10              


<210> 33
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 33
Cys Gly Gly Gly Ala Thr Arg Phe Ala Ser Val Tyr Ala Trp Asn Arg 
1               5                   10                  15      


Lys Arg Ile Ser Asn 
            20      


<210> 34
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 34
Cys Gly Gly Gly Ala Ile Ser Ser Val Leu Asn Asp Ile Leu Ser Arg 
1               5                   10                  15      


Leu Asp Lys Val Glu 
            20      


<210> 35
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 35
Cys Gly Gly Gly Lys Asn His Thr Ser Pro Asp Val Asp Leu Gly Asp 
1               5                   10                  15      


Ile Ser Gly Ile Asn 
            20      


<210> 36
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 36
Cys Gly Gly Gly Glu Ile Asp Arg Leu Asn Glu Val Ala Lys Asn Leu 
1               5                   10                  15      


Asn Glu Ser Leu Ile Asp Leu Gln Glu Leu 
            20                  25      


<210> 37
<211> 45
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> SITE
<222> (1)..(45)
<223> This sequence may encompass 1-15 "Gly Ser Gly"
      repeating units

<400> 37
Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly 
1               5                   10                  15      


Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser 
            20                  25                  30          


Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly 
        35                  40                  45  


<210> 38
<211> 60
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> SITE
<222> (1)..(60)
<223> This sequence may encompass 1-15 "Gly Pro Ser Leu"
      repeating units

<400> 38
Gly Pro Ser Leu Gly Pro Ser Leu Gly Pro Ser Leu Gly Pro Ser Leu 
1               5                   10                  15      


Gly Pro Ser Leu Gly Pro Ser Leu Gly Pro Ser Leu Gly Pro Ser Leu 
            20                  25                  30          


Gly Pro Ser Leu Gly Pro Ser Leu Gly Pro Ser Leu Gly Pro Ser Leu 
        35                  40                  45              


Gly Pro Ser Leu Gly Pro Ser Leu Gly Pro Ser Leu 
    50                  55                  60  


<210> 39
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> SITE
<222> (1)..(120)
<223> This sequence may encompass 1-15 
      "Gly Gly Ser Gly Gly Gly Ser Gly" repeating units

<400> 39
Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly 
1               5                   10                  15      


Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly 
            20                  25                  30          


Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly 
        35                  40                  45              


Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly 
    50                  55                  60                  


Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly 
65                  70                  75                  80  


Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly 
                85                  90                  95      


Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly 
            100                 105                 110         


Gly Gly Ser Gly Gly Gly Ser Gly 
        115                 120 


<210> 40
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 40
Gln Leu Tyr Lys Thr Cys Lys Gln Ala Gly Thr Cys Pro Pro Asp Gly 
1               5                   10                  15      


Gly Ser Gly Gly Gly Ser Gly Cys 
            20                  


<210> 41
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 41
Cys Gly Gly Gly 
1               


<210> 42
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 42
Gly Ser Gly Gly 
1               


<210> 43
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 43
Gly Gly Ser Gly 
1               


<210> 44
<211> 31
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 44
Gly Thr Gly Val Leu Thr Glu Ser Asn Lys Lys Phe Leu Pro Phe Gln 
1               5                   10                  15      


Gln Phe Gly Arg Asp Ile Asp Asp Thr Thr Asp Ala Val Arg Asp 
            20                  25                  30      


<210> 45
<211> 31
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 45
Gly Thr Gly Val Leu Thr Glu Ser Asn Lys Lys Phe Leu Pro Phe Gln 
1               5                   10                  15      


Gln Phe Gly Arg Asp Ile Ala Asp Thr Thr Asp Ala Val Arg Asp 
            20                  25                  30      


<210> 46
<211> 31
<212> PRT
<213> Severe acute respiratory syndrome-related coronavirus

<400> 46
Gly Thr Gly Val Leu Thr Pro Ser Ser Lys Arg Phe Gln Pro Phe Gln 
1               5                   10                  15      


Gln Phe Gly Arg Asp Val Ser Asp Phe Thr Asp Ser Val Arg Asp 
            20                  25                  30      


<210> 47
<211> 25
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 47
Glu Val Pro Val Ala Ile His Ala Asp Gln Leu Thr Pro Thr Trp Arg 
1               5                   10                  15      


Val Tyr Ser Thr Gly Ser Asn Val Phe 
            20                  25  


<210> 48
<211> 25
<212> PRT
<213> Severe acute respiratory syndrome-related coronavirus

<400> 48
Asp Val Ser Thr Ala Ile His Ala Asp Gln Leu Thr Pro Ala Trp Arg 
1               5                   10                  15      


Ile Tyr Ser Thr Gly Asn Asn Val Phe 
            20                  25  


<210> 49
<211> 33
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 49
Asn Phe Ser Gln Ile Leu Pro Asp Pro Ser Lys Pro Ser Lys Arg Ser 
1               5                   10                  15      


Phe Ile Glu Asp Leu Leu Phe Asn Lys Val Thr Leu Ala Asp Ala Gly 
            20                  25                  30          


Phe 
    


<210> 50
<211> 33
<212> PRT
<213> Severe acute respiratory syndrome-related coronavirus

<400> 50
Asn Phe Ser Gln Ile Leu Pro Asp Pro Leu Lys Pro Thr Lys Arg Ser 
1               5                   10                  15      


Phe Ile Glu Asp Leu Leu Phe Asn Lys Val Thr Leu Ala Asp Ala Gly 
            20                  25                  30          


Phe 
    


<210> 51
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 51
Cys Gly Gly Ser Gly Gly Gly Ser Gly Gln Leu Tyr Lys Thr Cys Lys 
1               5                   10                  15      


Gln Ala Gly Thr Cys Pro Pro Asp 
            20                  


<210> 52
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 52
Gln Leu Tyr Lys Thr Cys Lys Gln Ala Gly Thr Cys Pro Pro Asp Gly 
1               5                   10                  15      


Pro Ser Leu Cys 
            20  


<210> 53
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 53
Cys Gly Pro Ser Leu Gln Leu Tyr Lys Thr Cys Lys Gln Ala Gly Thr 
1               5                   10                  15      


Cys Pro Pro Asp 
            20  


